Dallas, TX -- (SBWIRE) -- 06/27/2011 -- GBI Research, the leading business intelligence provider, has released its latest research, “Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market”, which provides insights into global opioids market and market forecast until 2017. The report provides an in-depth analysis of the top seven therapeutic indications for which often opioids are prescribed which includes fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain. The report also examines the global opioids treatment usage patterns for the covered indication. In addition, the report also includes insights into the opioids R&D pipeline.

Report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

GBI Research analysis shows that the overall global opioids market for the seven indications fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain was valued at $11.2 billion in 2010. The market is expected to witness a CAGR of 2.8% for the forecast period. Patent expiries of leading opioids followed by generic erosions along with adverse effects associated with use of opioids are the main reasons for marginal growth in opioids market. However expected launch of new opioids is expected to push the market in future.

The US was the largest region for the opioids market in terms of revenue, accounting for 49% followed by top five countries in Europe and Japan which contributed 36% and 15% respectively.

The top pharmaceutical companies in opioids market are - Johnson & Johnson, Cephalon and several mid size players such as Purdue Pharma, King Pharmaceuticals, Orexo and Endo Pharmaceuticals. Large amount of fragmentation in the market provides significant scope for consolidation through mergers and acquisitions.

Scope
The scope of this report includes -
Data and analysis on the global opioids market.
Annualized market data for the opioids market from 2002 to 2010, with forecasts to 2017.
Market data on the therapeutic landscape which covers fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain therapeutics including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.

Key drivers and restraints that have had a significant impact on the market and on each indication.
The competitive landscape of the global opioids market which includes companies such as Johnson & Johnson, Cephalon, Purdue Pharma, King Pharmaceuticals, Orexo and Endo Pharmaceuticals.
Key M&A activities and Licensing Agreements that took place from 2005 to 2010 in the global opioids market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
Device a more tailored country strategy through the understanding of key drivers and barriers of the region’s opioids market.
Develop key strategic initiatives by understanding the key focus areas and top selling opioids molecules of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Buy Now: Opioids Market
http://www.reportsnreports.com/reports/83539-opioids-market-to-2017-steady-uptake-of-oxycontin-and-high-inci.html

Browse All: GBI Research Market Research Reports
http://www.reportsnreports.com/publisher/gbi-research/

Related Reports:
Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
Power Market in Western Europe to 2020 - Government Policies Downplaying the Nuclear Energy Industry and Spurring the Growth of Renewable Energy
Lifesciences IT - 2011 Yearbook
Specialty Pharmaceutical Industry - 2011 Yearbook
Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS

About ReportsnReports
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on:
Twitter: http://twitter.com/marketsreports
Facebook:http://www.facebook.com/pages/ReportsnReports/191441427571689
Blog : http://www.reportsnreportsblog.com/

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsnreports.com
Website: http://www.reportsnreports.com